MaxCyte, Inc. (MXCT) bonds
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3065% below fair value
$1.19+0.09 (+8.18%)
Close on Nov 12, 2026Market cap $122.82MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
MaxCyte reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in MaxCyte's 10-K for the period ended Dec 31, 2019
| Issue | Amount issued |
|---|---|
| Term Loan | $5.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?